| scholarly article | Q13442814 |
| P356 | DOI | 10.1161/01.CIR.101.20.2338 |
| P698 | PubMed publication ID | 10821806 |
| P2093 | author name string | Chandrasekar B | |
| Murray DR | |||
| Prabhu SD | |||
| P433 | issue | 20 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 2338-2341 | |
| P577 | publication date | 2000-05-01 | |
| P1433 | published in | Circulation | Q578091 |
| P1476 | title | Chronic beta-adrenergic stimulation induces myocardial proinflammatory cytokine expression | |
| P478 | volume | 101 |
| Q38433805 | A Comparison of Vasodilating and Non-vasodilating Beta-Blockers and Their Effects on Cardiometabolic Risk |
| Q35057999 | A systematic review concerning the relation between the sympathetic nervous system and heart failure with preserved left ventricular ejection fraction |
| Q33764603 | ATP-binding cassette transporter Abcg2 lineage contributes to the cardiac vasculature after oxidative stress |
| Q36072891 | Activation of AP-1 contributes to the beta-adrenoceptor-mediated myocardial induction of interleukin-6. |
| Q36003486 | Association of in vivo β-adrenergic receptor sensitivity with inflammatory markers in healthy subjects |
| Q55438072 | Atrial Cardiopathy and Sympatho-Vagal Imbalance in Cryptogenic Stroke: Pathogenic Mechanisms and Effects on Electrocardiographic Markers. |
| Q37623067 | Bench-to-bedside review: Beta-adrenergic modulation in sepsis. |
| Q55691195 | Bimodal Function of Anti-TNF Treatment: Shall We Be Concerned about Anti-TNF Treatment in Patients with Rheumatoid Arthritis and Heart Failure? |
| Q36771475 | Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects. |
| Q38046798 | Cardiac intercellular communication: are myocytes and fibroblasts fair-weather friends? |
| Q43244733 | Chronic beta-adrenergic activation-induced left ventricular systolic dysfunction is associated with systemic release of TNF-alpha and IL-1-beta in rats |
| Q36955252 | Combined milrinone and enteral metoprolol therapy in patients with septic myocardial depression |
| Q43957432 | Comparison of effects of carvedilol versus metoprolol on cytokine levels in patients with idiopathic dilated cardiomyopathy |
| Q24633065 | Cytokines sing the blues: inflammation and the pathogenesis of depression |
| Q53393279 | Early use of beta-blockers attenuates systemic inflammatory response and lung oxygenation impairment after distal type acute aortic dissection. |
| Q43595374 | Effect of beta-blockade on autonomic modulation of heart rate and neurohormonal profile in decompensated heart failure |
| Q41873186 | Effect of vildagliptin, a dipeptidyl peptidase 4 inhibitor, on cardiac hypertrophy induced by chronic beta-adrenergic stimulation in rats |
| Q42182846 | Efficacy of Carvedilol in Patients with Dilated Cardiomyopathy due to Beta-thalassemia major; a Double-blind Randomized Controlled Trial |
| Q43074266 | Exercise training inhibits inflammatory cytokines and more than prevents myocardial dysfunction in rats with sustained beta-adrenergic hyperactivity. |
| Q84572054 | Exercise training, inflammation and heart failure: working out to cool down |
| Q43002996 | Fractalkine (CX3CL1) stimulated by nuclear factor kappaB (NF-kappaB)-dependent inflammatory signals induces aortic smooth muscle cell proliferation through an autocrine pathway |
| Q34190623 | Genetic Profiling of α1-Adrenergic Receptor Subtypes by Oligonucleotide Microarrays: Coupling to Interleukin-6 Secretion but Differences in STAT3 Phosphorylation and gp-130 |
| Q36700001 | Genetic polymorphisms of the RAS-cytokine pathway and chronic kidney disease |
| Q56958327 | Heart rate following short-term beta-blocker titration predicts all-cause mortality in elderly chronic heart failure patients: insights from the CIBIS-ELD trial |
| Q38677735 | Induction of cardiac dysfunction in developing and adult zebrafish by chronic isoproterenol stimulation |
| Q26830867 | Inflammation and Nutritional Science for Programs/Policies and Interpretation of Research Evidence (INSPIRE). |
| Q36214658 | Inhaled beta2-adrenoceptor agonists: cardiovascular safety in patients with obstructive lung disease |
| Q38393039 | Innate immunity and the failing heart: the cytokine hypothesis revisited |
| Q41901744 | Isoproterenol Enhances Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand-Induced Apoptosis in Human Embryonic Kidney Cells through Death Receptor 5 up-Regulation |
| Q35119132 | Isoproterenol induces vascular oxidative stress and endothelial dysfunction via a Giα-coupled β2-adrenoceptor signaling pathway |
| Q36484609 | Knockout of beta(1)- and beta(2)-adrenoceptors attenuates pressure overload-induced cardiac hypertrophy and fibrosis |
| Q37115933 | Long-acting beta2-agonists (LABA) in chronic obstructive pulmonary disease: efficacy and safety |
| Q44654323 | Mineralocorticoids act centrally to regulate blood-borne tumor necrosis factor-α in normal rats |
| Q44494774 | Myocardial IL-6 regulation by neurohormones--an in vitro superfusion study |
| Q35758842 | Neuroimmune endocrine effects of antidepressants |
| Q35120861 | Pharmacologic therapy for patients with chronic heart failure and reduced systolic function: review of trials and practical considerations |
| Q37615822 | Pregnancy as a cardiac stress model |
| Q55499529 | Pro-Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction. |
| Q39070066 | Pro-inflammatory cytokines mediate GPCR dysfunction |
| Q33823097 | Pro-inflammatory responses in human monocytes are beta1-adrenergic receptor subtype dependent |
| Q34222962 | Recent insights into the role of tumor necrosis factor in the failing heart. |
| Q44348381 | Regulation of norepinephrine-induced proliferation in cardiac fibroblasts by interleukin-6 and p42/p44 mitogen activated protein kinase. |
| Q88711560 | Shock Management for Cardio-surgical ICU Patients - The Golden Hours |
| Q42784083 | TNF receptor signaling inhibits cardiomyogenic differentiation of cardiac stem cells and promotes a neuroadrenergic-like fate |
| Q35086445 | Temporal and gefitinib-sensitive regulation of cardiac cytokine expression via chronic β-adrenergic receptor stimulation |
| Q38140886 | The JAK-STAT pathway in hypertrophic stress signaling and genomic stress response |
| Q46561053 | The effects of prior beta-blocker therapy on serum C-reactive protein levels after percutaneous coronary intervention. |
| Q30320708 | The enhanced plasma levels of soluble tumor necrosis factor receptors (sTNF-R1; sTNF-R2) and interleukin-10 (IL-10) in patients suffering from chronic heart failure are reversed in patients treated with beta-adrenoceptor antagonist |
| Q35106477 | The role of anticytokine therapy in heart failure: recent lessons from preclinical and clinical trials? |
| Q38029531 | Using optogenetics to translate the "inflammatory dialogue" between heart and brain in the context of stress |
| Q80106735 | [Rationale and clinical evidence for the effects of new pharmacological treatments for heart failure] |
| Q80674241 | [Sensory-nerves and airway inflammation: interaction with beta-2-adrenoceptor agonists] |
| Q36159210 | β-Adrenergic receptors stimulate interleukin-6 production through Epac-dependent activation of PKCδ/p38 MAPK signalling in neonatal mouse cardiac fibroblasts |
| Q39992588 | β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo |
| Q92014236 | β2-adrenergic stimulation induces interleukin-6 by increasing Arid5a, a stabilizer of mRNA, through cAMP/PKA/CREB pathway in cardiac fibroblasts |
Search more.